☆ 4.4 Editorial Material

NIMRAD - A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer

CLINICAL ONCOLOGY (2014)

Get Full Text
Add to Collection

Journal

CLINICAL ONCOLOGY
Volume 26, Issue 6, Pages 344-347

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.clon.2014.03.003

Keywords

-

Categories

Oncology

Funding

  1. MRC [G0801525] Funding Source: UKRI
  2. Cancer Research UK [15729, 17977] Funding Source: researchfish
  3. Medical Research Council [G0801525] Funding Source: researchfish
  4. Cancer Research UK Funding Source: Medline
  5. Medical Research Council [G0801525] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.